These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

343 related items for PubMed ID: 16326126

  • 21. Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases.
    Paterson DL, Ko WC, Von Gottberg A, Mohapatra S, Casellas JM, Goossens H, Mulazimoglu L, Trenholme G, Klugman KP, Bonomo RA, Rice LB, Wagener MM, McCormack JG, Yu VL.
    Clin Infect Dis; 2004 Jul 01; 39(1):31-7. PubMed ID: 15206050
    [Abstract] [Full Text] [Related]

  • 22. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes.
    Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO.
    Clin Infect Dis; 2001 Apr 15; 32(8):1162-71. PubMed ID: 11283805
    [Abstract] [Full Text] [Related]

  • 23. [Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study].
    Gür D, Gülay Z, Akan OA, Aktaş Z, Kayacan CB, Cakici O, Eraç B, Gültekin M, Oğünç D, Söyletir G, Unal N, Uysal S.
    Mikrobiyol Bul; 2008 Oct 15; 42(4):537-44. PubMed ID: 19149074
    [Abstract] [Full Text] [Related]

  • 24. Extended spectrum beta lactamase producing gram negative bacilli in a tertiary referral hospital of Assam--experience with two methods.
    Nath R, Saikia L, Mahanta J.
    Indian J Pathol Microbiol; 2006 Oct 15; 49(4):623-5. PubMed ID: 17183880
    [Abstract] [Full Text] [Related]

  • 25. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome.
    Du B, Long Y, Liu H, Chen D, Liu D, Xu Y, Xie X.
    Intensive Care Med; 2002 Dec 15; 28(12):1718-23. PubMed ID: 12447513
    [Abstract] [Full Text] [Related]

  • 26. In vitro activities of 16 antimicrobial agents against clinical isolates of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in two regional hospitals in Taiwan.
    Liao CH, Sheng WH, Wang JT, Sun HY, Wang HK, Hsueh PR, Chen YC, Chang SC.
    J Microbiol Immunol Infect; 2006 Feb 15; 39(1):59-66. PubMed ID: 16440125
    [Abstract] [Full Text] [Related]

  • 27. Use of cefepime for the treatment of infections caused by extended spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
    Labombardi VJ, Rojtman A, Tran K.
    Diagn Microbiol Infect Dis; 2006 Nov 15; 56(3):313-5. PubMed ID: 17084784
    [Abstract] [Full Text] [Related]

  • 28. [Extended-spectrum beta-lactamase production and antimicrobial resistance patterns of Klebsiella pneumoniae strains isolated from nosocomial bacteremic patients: evaluation of the results of 2001-2005 period].
    Taşbakan MI, Pullukçu H, Sipahi OR, Aydemir S, Arda B, Yamazhan T, Tunger A, Ulusoy S.
    Mikrobiyol Bul; 2008 Jan 15; 42(1):1-7. PubMed ID: 18444557
    [Abstract] [Full Text] [Related]

  • 29. Antibiotic-resistance patterns and frequency of extended-spectrum beta-lactamase-producing isolates of Klebsiella pneumoniae in Tehran.
    Feizabadi MM, Etemadi G, Yadegarinia D, Rahmati M, Shabanpoor S, Bokaei S.
    Med Sci Monit; 2006 Nov 15; 12(11):BR362-5. PubMed ID: 17072265
    [Abstract] [Full Text] [Related]

  • 30. [Impact of extended-spectrum β-lactamase on clinical outcome and medical cost in patients with bloodstream infection due to Klebsiella pneumoniae].
    Li JQ, Tang CQ, Wang H, Ji SZ, Lü KY, Xiao SC, Deng AM, Huang Y, Xia ZF.
    Zhonghua Yi Xue Za Zhi; 2016 Jun 28; 96(24):1903-6. PubMed ID: 27373357
    [Abstract] [Full Text] [Related]

  • 31. Prevalence and significance of a negative extended-spectrum beta-lactamase (ESBL) confirmation test result after a positive ESBL screening test result for isolates of Escherichia coli and Klebsiella pneumoniae: results from the SENTRY Asia-Pacific Surveillance Program.
    Bell JM, Chitsaz M, Turnidge JD, Barton M, Walters LJ, Jones RN.
    J Clin Microbiol; 2007 May 28; 45(5):1478-82. PubMed ID: 17344367
    [Abstract] [Full Text] [Related]

  • 32. Effects of phenotype and genotype on methods for detection of extended-spectrum-beta-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway.
    Tofteland S, Haldorsen B, Dahl KH, Simonsen GS, Steinbakk M, Walsh TR, Sundsfjord A, Norwegian ESBL Study Group.
    J Clin Microbiol; 2007 Jan 28; 45(1):199-205. PubMed ID: 17079502
    [Abstract] [Full Text] [Related]

  • 33. Occurrence of extended-spectrum beta-lactamase in clinical isolates of Klebsiella pneumoniae in a University Hospital, Thailand.
    Kusum M, Wongwanich S, Dhiraputra C, Pongpech P, Naenna P.
    J Med Assoc Thai; 2004 Sep 28; 87(9):1029-33. PubMed ID: 15516002
    [Abstract] [Full Text] [Related]

  • 34. Distribution of TEM and SHV beta-lactamase genes among Klebsiella pneumoniae strains isolated from patients in Tehran.
    Shahcheraghi F, Moezi H, Feizabadi MM.
    Med Sci Monit; 2007 Nov 28; 13(11):BR247-250. PubMed ID: 17968291
    [Abstract] [Full Text] [Related]

  • 35. Risk factors for bloodstream infection caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: A focus on antimicrobials including cefepime.
    Chopra T, Marchaim D, Johnson PC, Chalana IK, Tamam Z, Mohammed M, Alkatib S, Tansek R, Chaudhry K, Zhao JJ, Pogue JM, Kaye KS.
    Am J Infect Control; 2015 Jul 01; 43(7):719-23. PubMed ID: 25934068
    [Abstract] [Full Text] [Related]

  • 36. Risk factors for infection and treatment outcome of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy.
    Kang CI, Chung DR, Ko KS, Peck KR, Song JH, Korean Network for Study of Infectious Diseases.
    Ann Hematol; 2012 Jan 01; 91(1):115-21. PubMed ID: 21556875
    [Abstract] [Full Text] [Related]

  • 37. Impact of extended spectrum beta-lactamase producing Klebsiella pneumoniae infections in severely burned patients.
    Bennett JW, Robertson JL, Hospenthal DR, Wolf SE, Chung KK, Mende K, Murray CK.
    J Am Coll Surg; 2010 Sep 01; 211(3):391-9. PubMed ID: 20800197
    [Abstract] [Full Text] [Related]

  • 38. [Short communication: Extended-spectrum beta-lactamase production in Klebsiella pneumoniae strains isolated from blood cultures and their antibiotic susceptibilities].
    Işik F, Arslan U, Tuncer I.
    Mikrobiyol Bul; 2008 Jan 01; 42(1):131-6. PubMed ID: 18444571
    [Abstract] [Full Text] [Related]

  • 39. [Prevalence of extended-spectrum beta-lactamases in nosocomial Escherichia coli and Klebsiella spp. strains isolated from blood cultures].
    Zarakolu P, Metan G, Hasçelik G, Akova M.
    Mikrobiyol Bul; 2007 Oct 01; 41(4):579-84. PubMed ID: 18173077
    [Abstract] [Full Text] [Related]

  • 40. [Molecular biology characteristics of ESBL-positive strains of Klebsiella pneumoniae collected in the Neonatal Unit of the Teaching Hospital in Olomouc].
    Kesselov M, Kolár M, Sauer P, Koukalová D, Petrzelová J, Vágnerová I, Kohnová I, Kantor L, Urbánek K.
    Klin Mikrobiol Infekc Lek; 2005 Feb 01; 11(1):20-4. PubMed ID: 15832259
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.